News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Hoffmann_Eitle Madrid_Barcelona
HOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN
Corporate
As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona…
CEISA Farmaforum
CEISA participates in the IX edition of Farmaforum
Access to innovation · Industrial biotechnology · Communication
On 20 and 21 September, CEISA will be present at Farmaforum, one of the most important events in…
BIOREPOS_instalaciones_biotecnología
Biorepository expands its facilities in Rivas Vaciamadrid
Access to innovation
The Galician company continues its national projection responding to the specific needs of its…
Grandient-AseBio-Asabys-Biotech
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
Healthcare · Innovative drugs
The funds will enable the company to advance the clinical development of its unique, minimally…
oryzon-genomics-asebio-ndp-biotech
ORYZON to give updates on corporate progress in September
BioSpain · Communication
The international conferences that will be attended include the H.C. Wainwright Global Investment…
genesis-biomed-socio-asebio-biotech
NLP will allow important advances in all fields, and especially in the field of health
Access to innovation · Digitalization
Natural language processing (NLP) systems are a key branch of artificial intelligence that…
Oncostellae Team
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park
Healthcare · Innovative drugs · Advanced therapies
The company specialises in the development of molecules for oncological and gastrointestinal…
Parque Científico de Barcelona
Barcelona Science Park companies break record after raising €142M in 2022
Healthcare · Access to innovation · Financing
2022 has been a historic year in economic and innovation indicators for the ecosystem of…
oryzon-noticia-socio-asebio-biotech
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemstat in Borderline Personality Disorder
Corporate
Multiple primary endpoints include reduction in agitation and aggression and overall disease…